UTAH MEDICAL PRODUCTS INC UTMD
UTAH MEDICAL PRODUCTS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($53.69); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
UTAH MEDICAL PRODUCTS INC trades at about 20.7× earnings — near its 10-year norm (10-year range 15.5×–39.5×, median 20.4×).
Shaded band = 10-year range (15.5×–39.5×); dot = today's 20.7×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 57.1% | 59.0% | 59.8% | 61.6% | 63.0% | 60.6% | 62.8% | 62.6% | 63.7% | 60.3% |
| Operating margin | 29.6% | 33.2% | 33.4% | 37.9% | 38.5% | 32.5% | 37.6% | 44.5% | 45.9% | 41.2% |
| FCF margin | 37.2% | 35.7% | 43.1% | 38.9% | 42.1% | 45.7% | 35.2% | 39.1% | 37.0% | 28.6% |
| Debt / equity | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× | — |
| Current ratio | 37.62 | 25.64 | 22.56 | 15.09 | 19.53 | 16.42 | 15.92 | 11.58 | 9.32 | 11.41 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.